The role of Kupffer cells in the hepatic response to silver nanoparticles

References

• Baffy G. 2009. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51:212–23
   PubMed Web of Science ®Google Scholar
• Bottcher JP, Knolle PA, Stabenow D. 2011. Mechanisms balancing tolerance and immunity in the liver. Dig Dis 29:384–90
   PubMed Web of Science ®Google Scholar
• Buzea C, Pacheco II, Robbie K. 2007. Nanomaterials and nanoparticles: sources and toxicity. Biointerpahses 2:18–67
   Web of Science ®Google Scholar
• Chen C, Zhang P, Hou X, Chai Z. 1999. Sub-cellular distribution of selenium and Se-containing proteins in human liver. Biochem Biophys Acta Gen Subjects 1427:205–15
   PubMed Web of Science ®Google Scholar
• Crispin JC, Tsokos GC. 2009. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun Rev 8:190–5
   PubMed Web of Science ®Google Scholar
• Cullen JM, Faiola B, Melich DH, Peterson RA, Jordan HL, Kimbrough CL, et al. 2013. Effects of Kupffer cell depletion on acute alpha-naphthylisothiocyante induced liver toxicity in male mice. Toxicol Pathol 41:7–17
   PubMed Web of Science ®Google Scholar
• Diesen DL, Kuo PC. 2009. Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res 162:95–109
   PubMed Web of Science ®Google Scholar
• Filippi C, Kermanizadeh A, Stone V. 2014. Kupffer cell contribution to the hepatic response to nanomaterials, in preparation
   Google Scholar
• Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et al. 2013. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 131(2):537–47
   PubMed Web of Science ®Google Scholar
• Geiser M, Kreyling WG. 2010. Deposition and biokenetics of inhaled nanoparticles. Part Fibre Toxicol 7:2–19
   PubMed Web of Science ®Google Scholar
• Hoet PHM, Hohlfeld IB, Salata O. 2004. Nanoparticles – known and unknown health risks. J Nanobiotechnol 2:12–27
   PubMedGoogle Scholar
• Jacobsen NR, Pojano G, Wallin H, Jensen KA. 2010. Nanomaterial dispersion protocol for toxicological studies in ENPRA. Internal ENPRA Project Report. The National Research Centre for the Working Environment. Available on request
   Google Scholar
• Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. 2012. Investigating the relationship between nanomaterial hazard and physicochemical properties: informing the exploitation of nanomaterials within therapeutic and diagnostic applications. J Control Release 164(3):307–13
   PubMed Web of Science ®Google Scholar
• Kermanizadeh A, Brown DM, Hutchison G, Stone V. 2013a. Engineered nanomaterial impact in the liver following exposure via an intravenous route – the role of polymorphonuclear leukocytes and gene expression in the organ. Nanomed Nanotechnol 4:157
   Google Scholar
• Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V. 2012. An in vitro liver model – assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanoparticles. Part Fibre Toxicol 9:28
   PubMed Web of Science ®Google Scholar
• Kermanizadeh A, Gaiser BK, Ward MB, Stone V. 2013b. Primary human hepatocytes vs. hepatic cell line – assessing their suitability for in vitro nanotoxicology. Nanotoxicology 7:1255–71
   PubMed Web of Science ®Google Scholar
• Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilaničová D, Wallin H, et al. 2013c. In vitro assessment of engineered nanomaterials using C3A cells: cytotoxicity, pro-inflammatory cytokines and function markers. Nanotoxiocology 7:301–13
   PubMed Web of Science ®Google Scholar
• Kmiec Z. 2001. Co-operation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161:1–151
   PubMedGoogle Scholar
• Li SX, Li B, Jiang HR, Wang Y, Qu ML, Duan HY, et al. 2013. Macrophage depletion impairs corneal wound healing after autologous transplantation in mice. PLoS One 8:4
   Web of Science ®Google Scholar
• Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, et al. 2010. Bio-distribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31:6574–81
   PubMed Web of Science ®Google Scholar
• Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. 2004. The dual role of IL10. Trends Immunol 24:36–43
   Web of Science ®Google Scholar
• Moelants EAV, Mortier A, Van Damme J, Proost P. 2013. Regulation of TNF-alpha with a focus on rheumatoid arthritis. Immunol Cell Biol 91:393–401
   PubMed Web of Science ®Google Scholar
• Moore KW, Malefyt R, Coffman RL, O’Garra A. 2001. Interluekin-10 and the interluekin-10 receptor. Annu Rev Immunol 19:683–765
   PubMed Web of Science ®Google Scholar
• Nemeth E, Baird AW, O’Farrelly C. 2009. Microanatomy of the liver immune system. Semin Immunopathol 31:333–43
   PubMed Web of Science ®Google Scholar
• Novak ML, Koh TJ. 2013. Macrophage phenotypes during tissue repair. J Leukocyte Biol 93:875–81
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:2–25
   Web of Science ®Google Scholar
• Papp T, Schiffmann D, Weiss D, Castronova V, Vallyathan V, Rahman Q. 2008. Human health implications of nonmaterial exposure. Nanotoxicology 2:9–27
   Web of Science ®Google Scholar
• Pillai MR, Bix M. 2011. Evolution of IL4 and pathogen antagonism. Growth Factors 29:153–60
   PubMed Web of Science ®Google Scholar
• Sadauskas E, Jacobson NR, Danscher G, Soltenberg M, Larsen A, Kreyling W, Wallin H. 2009. Bio-disruption of gold nanoparticles in mouse lung following intratracheal instillation. Chem Central J 3:16–23
   PubMed Web of Science ®Google Scholar
• Seki A, Sakai Y, Komura T, Higashimoto M, Fujinaga H, Honda M, et al. 2012. Therapeutic effect of adipose derived mesenchymal stem cell to murine NASH liver cirrhosis inactivating Kupffer/Macrophage and helper T cell. Hepatology 56:S1101A
   Google Scholar
• Semmler-Behnke M, Wolfgang KG, Lipka J, Fertsch S, Wenk A, Takeneka S, et al. 2008. Bio-distribution of 1.4 and 18 nm gold particles in rats. Small 12:2108–11
   Web of Science ®Google Scholar
• Sharma A, Madhunapantula SV, Robertson GP. 2012. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol 8(1):47–69
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of anti-platelet properties of silver nanoparticles. ACS Nano 3(6):1357–64
   PubMed Web of Science ®Google Scholar
• Singh RP, Ramarao P. 2012. Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett 213:249–59
   PubMed Web of Science ®Google Scholar
• Swenson-Fields KI, Vivian CJ, Salah SM, Peda JD, Davis BM, van Rooijen N, et al. 2013. Macrophage promote polycystic kidney disease progression. Kidney Int 83:855–64
   PubMed Web of Science ®Google Scholar
• Tiegs G, Lohse AW. 2009. Immune tolerance: what is unique about the liver. J Autoimmun 34:1–6
   PubMed Web of Science ®Google Scholar
• van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28 day oral exposure. ACS Nano 6:7427–42
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell “sees” in bionanoscience. J Am Chem Soc 132:5761--8
   Google Scholar
• Woodrow Wilson. Available from: http://www.nanotechproject.org/inventories/consumer/browse/products/. Accessed on 14 February 2013
   Google Scholar